Notify me when FIRST NATIONAL CORP /MA/ /ADV files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 174 | $527,481,709 | +$19,218,225 | -$17,785,955 | +$1,432,270 | SPY, USFR, SCHB, GLD, SCHX | 13F-HR | 27 Oct 2025, 19:06 |
| Q2 2025 | 163 | $496,045,843 | +$48,020,165 | -$28,047,813 | +$19,972,352 | SPY, USFR, SCHB, GLD, SCHX | 13F-HR | 08 Jul 2025, 16:38 |
| Q1 2025 | 160 | $452,946,091 | +$35,497,791 | -$19,576,681 | +$15,921,110 | SPY, GLD, SCHB, SH, SCHD | 13F-HR | 11 Apr 2025, 10:15 |
| Q4 2024 | 153 | $441,706,186 | +$104,398,260 | -$49,112,579 | +$55,285,681 | SPY, SCHB, GLD, SH, AAPL | 13F-HR | 29 Jan 2025, 10:35 |
| Q3 2024 | 145 | $449,601,451 | +$66,277,245 | -$62,376,673 | +$3,900,572 | SPY, GLD, SCHB, SH, USFR | 13F-HR | 08 Oct 2024, 15:10 |
| Q2 2024 | 155 | $419,864,960 | +$28,486,050 | -$33,782,066 | -$5,296,016 | SPY, SCHB, USFR, SCHX, AAPL | 13F-HR | 12 Jul 2024, 13:58 |
| Q1 2024 | 154 | $383,067,230 | $0 | -$722,654 | -$722,654 | SCHB, SPY, USFR, AAPL, SCHD | 13F-HR | 15 Apr 2024, 12:04 |
| Q4 2023 | 154 | $407,534,543 | +$23,747,103 | -$22,610,876 | +$1,136,227 | SCHB, SPY, USFR, AAPL, SCHD | 13F-HR | 18 Jan 2024, 08:40 |
| Q3 2023 | 147 | $372,400,913 | +$11,117,390 | -$38,146,174 | -$27,028,784 | SCHB, SPY, USFR, AAPL, SCHD | 13F-HR | 24 Oct 2023, 10:20 |
| Q2 2023 | 157 | $421,268,786 | +$37,054,358 | -$50,490,353 | -$13,435,995 | SCHB, SPY, VPU, USFR, AAPL | 13F-HR | 31 Jul 2023, 09:15 |
| Q1 2023 | 164 | $420,389,361 | +$30,651,072 | -$30,528,874 | +$122,198 | SCHB, SPY, VPU, TLT, USFR | 13F-HR | 27 Apr 2023, 17:48 |
| Q4 2022 | 154 | $404,523,899 | +$69,034,963 | -$48,298,090 | +$20,736,873 | TLT, SCHB, VPU, SPY, SCHD | 13F-HR | 26 Jan 2023, 10:54 |
| Q3 2022 | 152 | $361,521,000 | +$29,171,050 | -$24,722,363 | +$4,448,687 | VPU, TLT, SPY, SCHB, STIP | 13F-HR | 24 Oct 2022, 11:34 |
| Q2 2022 | 154 | $382,343,000 | +$43,732,577 | -$75,506,375 | -$31,773,798 | TLT, VPU, STIP, SPY, SCHB | 13F-HR | 18 Jul 2022, 11:09 |
| Q1 2022 | 163 | $471,749,000 | +$126,394,957 | -$47,349,695 | +$79,045,262 | TLT, SCHB, SPY, STIP, AAPL | 13F-HR | 26 Apr 2022, 13:23 |
| Q4 2021 | 159 | $447,206,000 | +$30,359,832 | -$60,887,279 | -$30,527,447 | SCHB, SOXX, SPY, AAPL, SDY | 13F-HR | 28 Jan 2022, 13:15 |
| Q3 2021 | 161 | $445,961,000 | +$86,314,121 | -$8,792,395 | +$77,521,726 | TLT, SCHB, SOXX, SPY, SCHF | 13F-HR | 09 Nov 2021, 12:06 |
| Q2 2021 | 140 | $86,903,000 | $0 | $0 | $0 | LQD, AWK, VPU, LDUR, STIP | Restatement | 30 Jul 2021, 15:50 |
| Q1 2021 | 152 | $403,054,000 | +$41,951,534 | -$20,968,418 | +$20,983,116 | SCHB, SOXX, TLT, SPY, SCHF | 13F-HR | 10 May 2021, 07:38 |
| Q4 2020 | 150 | $365,719,000 | +$24,822,083 | -$1,411,362 | +$23,410,721 | SCHB, SOXX, SCHF, SPY, TLT | 13F-HR | 08 Feb 2021, 08:10 |
| Q3 2020 | 146 | $8,947,000 | $0 | $0 | $0 | SCO, BSCM, VEU, BSCO, VT | 13F-HR | 22 Oct 2020, 08:23 |
| Q2 2020 | 141 | $290,047,000 | +$54,282,286 | -$4,466,920 | +$49,815,366 | SOXX, SCHB, SCHH, SCHF, SPY | 13F-HR | 21 Jul 2020, 15:22 |
| Q1 2020 | 132 | $13,121,249 | $0 | $0 | $0 | DBO, EKSO, Nabriva Therapeutics AG ADR, SMMU, BSMM | 13F-HR | 16 Apr 2020, 17:19 |
| Q4 2019 | 145 | $267,414,000 | +$11,277,928 | -$6,753,770 | +$4,524,158 | SCHB, SOXX, SCHA, SCHM, TLT | 13F-HR | 31 Jan 2020, 12:04 |
| Q3 2019 | 141 | $246,967,000 | +$9,018,176 | -$7,357,165 | +$1,661,011 | SCHB, SOXX, SCHA, TLT, SCHM | 13F-HR | 24 Oct 2019, 08:37 |
| Q2 2019 | 137 | $240,952,000 | +$17,216,666 | -$19,977,185 | -$2,760,519 | SCHB, SOXX, SCHA, SCHM, TLT | 13F-HR | 29 Jul 2019, 19:10 |
| Q1 2019 | 471 | $238,529,000 | +$26,131,402 | -$27,693,588 | -$1,562,186 | SCHB, SCHM, SOXX, SCHA, LQD | Restatement | 18 Jun 2019, 10:17 |
| Q4 2018 | 411 | $217,042,000 | $0 | $0 | $0 | SCHB, TLT, SCHA, SCHM, SDY | 13F-HR | 12 Jun 2019, 16:44 |